Literature DB >> 19424681

Blockade of HERG K+ channel by isoquinoline alkaloid neferine in the stable transfected HEK293 cells.

Dong-fang Gu1, Xue-lian Li, Zhi-ping Qi, Sha-shan Shi, Mei-qin Hu, Dong-min Liu, Cheng-bai She, Yan-jie Lv, Bao-xin Li, Bao-feng Yang.   

Abstract

We studied the effects of isoquinoline alkaloid neferine (Nef) extracted from the seed embryo of Nelumbo nucifera Gaertn on Human ether-à-go-go-related gene (HERG) channels stably expressed in human embryonic kidney (HEK293) cells using whole-cell patch clamp technique, western blot analysis and immunofluorescence experiment. Nef induced a concentration-dependent decrease in current amplitude according to the voltage steps and tail currents of HERG with an IC(50) of 7.419 microM (n(H) -0.5563). Nef shifted the activation curve in a significantly negative direction and accelerated recovery from inactivation and onset of inactivation, however, slowed deactivation. In addition, it had no significant influence on steady-state inactivation curve. Western blot and immunofluorescence results suggested Nef had no significant effect on the expression of HERG protein. In summary, Nef can block HERG K(+) channels that functions by changing the channel activation and inactivation kinetics. Nef has no effect on the generation and trafficking of HERG protein. A blocked-off HERG channel was one mechanism of the anti-arrhythmic effects by Nef.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19424681     DOI: 10.1007/s00210-009-0419-7

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  26 in total

1.  Role of glycosylation in cell surface expression and stability of HERG potassium channels.

Authors:  Qiuming Gong; Corey L Anderson; Craig T January; Zhengfeng Zhou
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-07       Impact factor: 4.733

2.  [Effects of neferine on physiologic properties and dose-effect response of isoprenaline and Ca2+ in guinea pig atria].

Authors:  G R Li; F H Lue; J Q Qian
Journal:  Yao Xue Xue Bao       Date:  1988-04

3.  Inhibitory effects of berberine on IK1, IK, and HERG channels of cardiac myocytes.

Authors:  B X Li; B F Yang; J Zhou; C Q Xu; Y R Li
Journal:  Acta Pharmacol Sin       Date:  2001-02       Impact factor: 6.150

4.  Drug-induced long QT syndrome: hERG K+ channel block and disruption of protein trafficking by fluoxetine and norfluoxetine.

Authors:  S Rajamani; L L Eckhardt; C R Valdivia; C A Klemens; B M Gillman; C L Anderson; K M Holzem; B P Delisle; B D Anson; J C Makielski; C T January
Journal:  Br J Pharmacol       Date:  2006-09-11       Impact factor: 8.739

5.  Reduction of hERG potassium currents by hyperosmolar solutions.

Authors:  Fumie Yabuuchi; Rolf Beckmann; Erich Wettwer; Christa Hegele-Hartung; Jürgen F Heubach
Journal:  Eur J Pharmacol       Date:  2007-03-24       Impact factor: 4.432

6.  Inhibition of hERG K+ currents by antimalarial drugs in stably transfected HEK293 cells.

Authors:  Martin Traebert; Bérengère Dumotier; Lothar Meister; Peter Hoffmann; Manuel Dominguez-Estevez; Willi Suter
Journal:  Eur J Pharmacol       Date:  2004-01-19       Impact factor: 4.432

Review 7.  The hERG potassium channel and hERG screening for drug-induced torsades de pointes.

Authors:  Jules C Hancox; Mark J McPate; Aziza El Harchi; Yi Hong Zhang
Journal:  Pharmacol Ther       Date:  2008-06-18       Impact factor: 12.310

Review 8.  hERG potassium channels and cardiac arrhythmia.

Authors:  Michael C Sanguinetti; Martin Tristani-Firouzi
Journal:  Nature       Date:  2006-03-23       Impact factor: 49.962

9.  A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel.

Authors:  M C Sanguinetti; C Jiang; M E Curran; M T Keating
Journal:  Cell       Date:  1995-04-21       Impact factor: 41.582

10.  Mechanisms of arsenic-induced prolongation of cardiac repolarization.

Authors:  Eckhard Ficker; Yuri A Kuryshev; Adrienne T Dennis; Carlos Obejero-Paz; Lu Wang; Peter Hawryluk; Barbara A Wible; Arthur M Brown
Journal:  Mol Pharmacol       Date:  2004-07       Impact factor: 4.436

View more
  7 in total

1.  State-dependent blockade of human ether-a-go-go-related gene (hERG) K(+) channels by changrolin in stably transfected HEK293 cells.

Authors:  Wei-hai Chen; Wen-yi Wang; Jie Zhang; Ding Yang; Yi-ping Wang
Journal:  Acta Pharmacol Sin       Date:  2010-08       Impact factor: 6.150

Review 2.  Biologically active isoquinoline alkaloids covering 2014-2018.

Authors:  Xiao-Fei Shang; Cheng-Jie Yang; Susan L Morris-Natschke; Jun-Cai Li; Xiao-Dan Yin; Ying-Qian Liu; Xiao Guo; Jing-Wen Peng; Masuo Goto; Ji-Yu Zhang; Kuo-Hsiung Lee
Journal:  Med Res Rev       Date:  2020-07-29       Impact factor: 12.944

3.  Inhibitory effects of neferine on Nav1.5 channels expressed in HEK293 cells.

Authors:  Chen Wang; Huan Wang; Jun-Hua Xiao; Jia-Ling Wang; Ji-Zhou Xiang; Qiang Tang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-07-28

4.  Effects of neferine on Kv4.3 channels expressed in HEK293 cells and ex vivo electrophysiology of rabbit hearts.

Authors:  Chen Wang; Yu-fang Chen; Xiao-qing Quan; Huan Wang; Rui Zhang; Jun-hua Xiao; Jia-ling Wang; Cun-tai Zhang; Ji-zhou Xiang; Qiang Tang
Journal:  Acta Pharmacol Sin       Date:  2015-11-23       Impact factor: 6.150

5.  The rescuable function and mechanism of resveratrol on As₂O₃-induced hERG K⁺ channel deficiency.

Authors:  Xin Zhao; Kai-Ping Zhang; Ting Huang; Cai-Chuan Yan; Li-Rong Liu; Qi-Lei Zhu; Feng-Feng Guo; Chen Liu; Bao-Xin Li
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-08-10       Impact factor: 3.000

Review 6.  Natural products modulating the hERG channel: heartaches and hope.

Authors:  Jadel M Kratz; Ulrike Grienke; Olaf Scheel; Stefan A Mann; Judith M Rollinger
Journal:  Nat Prod Rep       Date:  2017-08-02       Impact factor: 13.423

7.  Mechanisms underlying probucol-induced hERG-channel deficiency.

Authors:  Yuan-Qi Shi; Cai-Chuan Yan; Xiao Zhang; Meng Yan; Li-Rong Liu; Huai-Ze Geng; Lin Lv; Bao-Xin Li
Journal:  Drug Des Devel Ther       Date:  2015-07-20       Impact factor: 4.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.